SHIVA: Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer-PFS ratio from patients who crossed-over.

Affiliation auteurs!!!! Error affiliation !!!!
TitreSHIVA: Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer-PFS ratio from patients who crossed-over.
Type de publicationJournal Article
Year of Publication2016
AuteursLe Tourneau C, Kamal M, Mauborgne C, Mulot F, Delord J-P, Goncalves A, Gavoille C, Dubot C, Isambert N, Campone M, Tredan O, Ricci F, Alt M, Loirat D, Sablin M-P, Paoletti X, Servois V, Belin L
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.2535